Free Daily Podcast Summary
Psychopharmacology and Psychiatry Updates: Daily Summaries Delivered
by Psychopharmacology Institute
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 5 days ago11 min
Could Lithium Play a Role in Preventing Alzheimer's Disease?
In this episode, we explore a striking new Nature study suggesting that lithium deficiency may play a central role in the onset of Alzheimer's disease. Could a simple, overlooked supplement be the key to prevention? Dr. Scott Beach unpacks the science, the promise, and the important caveats. Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 81 Lithium Orotate: Breakthrough Treatment for Alzheimer's Disease?
- 1 weeks ago8 min
Managing ADHD in Pregnancy: Weighing Risk versus Risk
In this episode, we explore the nuanced challenge of managing ADHD with stimulant medications during pregnancy. Is stopping the medication always the safer choice — or does untreated ADHD carry risks of its own? Dr. Amanda Koire breaks down the latest evidence to help clinicians make truly informed decisions. Faculty: Amanda Koire, M.D., Ph.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know Pregnancy, ADHD, and Stimulants: Making an Informed Choice
- 2 weeks ago13 min
Ondansetron for Negative Symptoms of Schizophrenia
In this episode, we examine a surprising repurposing of ondansetron — a common antiemetic — as a potential adjunctive treatment for the notoriously hard-to-treat negative symptoms of schizophrenia. Could a nausea medication help restore motivation and emotional engagement in your patients with residual symptoms despite stable antipsychotic therapy? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 81 Is Ondansetron Effective for Negative Symptoms in Schizophrenia?
- 2 weeks ago7 min
Managing SSRIs During Pregnancy: Myths vs. Evidence
In this episode, we explore how to manage SSRI treatment in pregnant patients — addressing common fears around fetal malformations, medication switching, and neonatal withdrawal. Can stopping an antidepressant actually do more harm than continuing it? Faculty: Amanda Koire, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know SSRI Treatment During Pregnancy: A Clinical Case
- 3 weeks ago14 min
Rethinking Haloperidol's Cardiac Risk
In this episode, we explore a landmark meta-analysis that challenges decades of fear surrounding IV haloperidol and cardiac risk. Could one of medicine's most persistent myths be costing patients their best treatment option for delirium? Dr. Scott Beach breaks down the evidence. Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 80 IV Haloperidol: Are Cardiac Safety Concerns Overblown?
- May 6, 202611 min
Bipolar Disorder, Lithium, and Pregnancy: What the Evidence Says
In this episode, we explore the complex risk-versus-risk decision of using lithium during pregnancy and breastfeeding. How do you weigh the near-certainty of mood relapse against fetal cardiac risks? Dr. Amanda Koire provides a practical framework every clinician needs when managing bipolar disorder in reproductive-age women. Faculty: Amanda Koire, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know Lithium in Pregnancy and Breastfeeding
- May 1, 202612 min
Clozapine Monitoring: New Guidelines for the Post-REMS Era
In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 79 New Guidelines for Clozapine ANC Monitoring
- Apr 26, 20269 min
Prescribing Through Pregnancy: Dosing, Levels, and Relapse Risk
In this episode, we explore how pregnancy reshapes the pharmacokinetics of psychiatric medications — and what that means for your patients. Can stopping a mood stabilizer actually put a pregnancy at greater risk than continuing it? Dr. Amanda Koire breaks down the evidence. Faculty: Amanda Koire, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know Pregnancy's Impact on Medication Efficacy and Dosing Considerations
About Psychopharmacology and Psychiatry Updates
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Psychopharmacology and Psychiatry Updates in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Psychopharmacology and Psychiatry Updates daily summary?
It's a free AI-powered email that summarizes new episodes of Psychopharmacology and Psychiatry Updates as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Psychopharmacology and Psychiatry Updates podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Psychopharmacology and Psychiatry Updates product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Psychopharmacology Institute.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Psychopharmacology and Psychiatry Updates release new episodes?
Psychopharmacology and Psychiatry Updates publishes 2x weekly. Our AI generates a summary within hours of each new episode.
What topics does Psychopharmacology and Psychiatry Updates cover?
Psychopharmacology and Psychiatry Updates covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Psychopharmacology and Psychiatry Updates summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.